7:41 AM
 | 
Dec 06, 2018
 |  BC Extra  |  Politics & Policy

Newly named Azar adviser O'Brien defends pricing index

Editor's Note: This article was updated on Dec 06, 2018 at 3:09 PM PST

John O'Brien is taking over as the point person on the Trump administration's drug pricing strategy as its plans to tie Medicare Part B drug prices to an international reference pricing scheme have come under fire.

HHS Secretary Alex Azar named O'Brien senior adviser to the secretary for drug pricing reform Thursday, where he will be responsible for coordinating the implementation of the Trump administration's drug pricing blueprint.

The role as been vacant since Dan Best passed away in November.

Previously adviser to the secretary for health reform and drug pricing, and deputy assistant secretary for health policy at the Office of the Assistant Secretary...

Read the full 513 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >